Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

26.41 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
Exploring the top movers within the S&P500 index during today's session.
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Earnings Scheduled For November 6, 2025
 
Via Benzinga
Q3 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Moderna (NASDAQ:MRNA) and its peers. 
Via StockStory
Topics Artificial Intelligence
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Telemark Asset Management Builds Position in Beaten-Down Biotech Stock.
Telemark Asset Management Builds Position in Beaten-Down Biotech Stock. 
Via The Motley Fool
Topics Regulatory Compliance
S&P 500 Breaches Key Support: A Signal of Deepening Market Weakness
The S&P 500 index has recently fallen below its crucial 50-day moving average, a technical event that is sending ripples of concern throughout global financial markets. This breach, occurring as of... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Wall Street Slips as Job Cuts and Shutdown Fears Shake Confidence
Investors brace for weaker labor data and prolonged government paralysis while AI-fueled volatility rattles the markets. 
Via Chartmill
MRNA Q3 Deep Dive: Cost Controls and Pipeline Progress Amid Declining COVID Vaccine Demand
Biotechnology company Moderna (NASDAQ:MRNA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s... 
Via StockStory
AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday?
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto... 
Via Benzinga
Topics Artificial Intelligence
mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast
Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand declines. 
Via Benzinga
Moderna Q3 2025 Earnings Call Transcript
Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below. 
Via Benzinga
Topics Earnings
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
Moderna Inc (NASDAQ:MRNA) Reports Q3 2025 Revenue Beat and Narrower-Than-Expected Loss
Moderna's Q3 2025 earnings beat revenue estimates with $1.016B and a narrower loss. Shares rose on strong COVID vaccine sales and an improved 2025 financial outlook. 
Via Chartmill
Topics Earnings
Moderna Surges; Covid Vaccine Sales Decline, But Top Expectations
Moderna stock surged Thursday. Though third-quarter vaccine sales declined, they came in above expectations. 
Via Investor's Business Daily
Moderna (NASDAQ:MRNA) Posts Better-Than-Expected Sales In Q3, Stock Soars
Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s full-year... 
Via StockStory
Topics Artificial Intelligence Supply Chain
Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates
Via ACCESS Newswire
Services Sector Soars, Dispelling Economic Gloom and Fueling U.S. Stock Market Rally
Washington D.C., November 5, 2025 – The U.S. services sector has delivered a powerful jolt of optimism to financial markets, with robust Purchasing Managers' Index (PMI) data for October 2025 largely... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
Moderna Earnings: What To Look For From MRNA
Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Thursday before the bell. Here’s what investors should know. 
Via StockStory
Moderna Stock Is Sliding Monday: What's Going On?
Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news. 
Via Benzinga
Stay informed with the top movers within the S&P500 index on Monday.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday. 
Via Chartmill
Why Moderna (MRNA) Stock Is Falling Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an... 
Via StockStory
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Gapping S&P500 stocks in Monday's session
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends. 
Via Chartmill
Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
Via ACCESS Newswire
Why Moderna (MRNA) Stock Is Trading Lower Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock retreated, giving back some of the strong gains from the previous session that were fueled by... 
Via StockStory
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.